39 results
DEF 14C
OCEL
Organicell Regenerative Medicine, Inc.
20 Dec 23
Information statement
6:30am
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us.” “our” or the “Company”) in full satisfaction of any notice
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
11 Dec 23
Preliminary information
5:22pm
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us.” “our” or the “Company”) in full satisfaction of any notice
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
28 Sep 23
Preliminary information
2:54pm
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us,” “our,” or the “Company”) in full satisfaction of any
DEF 14C
pz6e0xefzbwbh6d
14 Aug 23
Information statement
4:34pm
PRE 14C
a4m4ns26940l149c
1 Aug 23
Preliminary information
4:15pm
8-K
vq9lq1u
21 Apr 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
EX-10.1
6c01p
6 Sep 22
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-99.1
hoxej2ccb8d92z9pq5
20 Jul 22
Organicell Regenerative Medicine, Inc. Secures $4 Million In Funding for Clinical Trials and Agrees to Restructure Management
10:19am
8-K
5m0ab ya63o
19 Jul 22
Entry into a Material Definitive Agreement
4:41pm
S-8
EX-99.1
uz2rqph6hhq 8240b3
1 Nov 21
Registration of securities for employees
12:00am
DEF 14C
9tzwpiiiwxg9
5 Oct 21
Information statement
6:00am
PRER14C
wuih9ehbvta4
4 Oct 21
Preliminary revised information
6:02am
PRER14C
98jyicowpl 5498j
30 Sep 21
Preliminary revised information
6:01am
PRE 14C
rn87tdh4o39c qwjticm
24 Sep 21
Preliminary information
5:25pm